Adenocarcinoma of the uterine corpus and sarcomas of the uterus

William T. Creasman, David S. Miller, Ramez N. Eskander, Matthew Powell

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Endometrial cancer remains the only gynecologic malignancy with a rising incidence and mortality. Although diagnostic techniques have evolved modestly, the surgical management of endometrial cancer was transformed with incorporation of sentinel lymph node dissection paradigms. Furthermore, significant gains have been achieved in molecular characterization of endometrial cancer, with publication of The Cancer Genome Atlas (TCGA) endometrial and subsequent studies. Incorporation of molecular diagnostics has ushered in immunotherapy as an effective treatment strategy in select patients, with alternate targeted therapies emerging as promising options.

Original languageEnglish
Title of host publicationDiSaia and Creasman Clinical Gynecologic Oncology
Number of pages50
ISBN (Electronic)9780323776844
ISBN (Print)9780323776868
StatePublished - Jan 1 2023


  • Endometrial cancer
  • epidemiology
  • immunotherapy
  • molecular characterization
  • sarcoma
  • sentinel lymph nodes
  • surgical management
  • systemic therapy
  • targeted therapy


Dive into the research topics of 'Adenocarcinoma of the uterine corpus and sarcomas of the uterus'. Together they form a unique fingerprint.

Cite this